Brian T. Fisher, DO, MPH, MSCE

Brian Fisher, DO, MPH, MSCE, is the director of the Pediatric Infectious Diseases Fellowship Training Program and a senior scholar within the Penn Center for Clinical Epidemiology and Biostatistics. 

Areas of Expertise: Infections in immunocompromised children
Locations: Main Campus
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

  • Education and Training

    Residency

    General Pediatrics - Hope Children's Hospital, Oak Lawn, IL

    Fellowship

    Pediatric Infectious Diseases - The Children's Hospital of Philadelphia, Philadelphia, PA

    Board Certification

    Pediatric Infectious Diseases
    Pediatrics

    Undergraduate Degree

    DO - Chicago College of Osteopathic Medicine, Chicago, IL
    MPH in Epidemiology - University of Illinois at Chicago, Chicago, IL
    MS in Clinical Epidemiology - University of Pennsylvania, Philadelphia, PA

  • Titles and Academic Titles

    Attending Physician

    Director, Pediatric Infectious Diseases Fellowship Training Program

    Assistant Professor of Pediatrics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania

  • Departments and Services
  • Research Interests

    Dr. Fisher's research focuses on infections in children with immunocompromising conditions. He is particularly interested in infections in children with cancer and serves as the Chair of the Infectious Disease Domain within the Children’s Oncology Group.

  • Publications

    Papers

    2015

    Miller TP, Troxel AB, Li Y, Huang YS, Alonzo TA, et al. Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer. 2015; 62(7):1184-9. NIHMSID: NIHMS659308

    Chellapandian D, Lehrnbecher T, Phillips B, Fisher BT, Zaoutis TE, et al. Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015; 33(5):501-9.

    Seif AE, Walker DM, Li Y, Huang YS, Kavcic M, et al. Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients. Pediatric blood & cancer. 2015; 62(4):704-9. NIHMSID: NIHMS581111

    2014

    Goodman EK, Reilly AF, Fisher BT, Fitzgerald J, Li Y, et al. Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals. JAMA pediatrics. 2014; 168(10):925-31. NIHMSID: NIHMS681278

    Freedman JL, Faerber J, Kang TI, Dai D, Fisher BT, et al. Predictors of antiemetic alteration in pediatric acute myeloid leukemia. Pediatric blood & cancer. 2014; 61(10):1798-805. NIHMSID: NIHMS607842

    Palazzi DL, Arrieta A, Castagnola E, Halasa N, Hubbard S, et al. Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study. The Pediatric infectious disease journal. 2014; 33(12):1294-6.

    Desai AV, Kavcic M, Huang YS, Herbst N, Fisher BT, et al. Establishing a high-risk neuroblastoma cohort using the Pediatric Health Information System Database. Pediatric blood & cancer. 2014; 61(6):1129-31. NIHMSID: NIHMS637631

    Maude SL, Fitzgerald JC, Fisher BT, Li Y, Huang YS, et al. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2014; 15(2):112-20. NIHMSID: NIHMS681302

    Fisher BT, Kavcic M, Li Y, Seif AE, Bagatell R, et al. Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014; 58(4):502-8.

    Seif AE, Fisher BT, Li Y, Torp K, Rheam DP, et al. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatric blood & cancer. 2014; 61(5):846-52. NIHMSID: NIHMS545529

    Lee GE, Sung L, Fisher BT, Sullivan KE, McWilliams T, et al. Gene expression profiling to predict viridans group streptococcal and invasive fungal infection in pediatric acute myeloid leukemia: a brief report from the Children's Oncology Group. Acta haematologica. 2014; 131(3):167-9. NIHMSID: NIHMS689342

    Fisher BT, Ross RK, Localio AR, Prasad PA, Zaoutis TE. Decreasing rates of invasive candidiasis in pediatric hospitals across the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014; 58(1):74-7.

    Fisher BT, Singh S, Huang YS, Li Y, Gregory J, et al. v Pediatric blood & cancer. 2014; 61(1):68-73. NIHMSID: NIHMS550131

    2013

    Prasad PA, Fisher BT, Coffin SE, Walsh TJ, McGowan KL, et al. Pediatric Risk Factors for Candidemia Secondary to Candida glabrata and Candida krusei Species. Journal of the Pediatric Infectious Diseases Society. 2013; 2(3):263-266.